These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31408248)

  • 1. Heavy cannabis use, dependence and the brain: a clinical perspective.
    Kroon E; Kuhns L; Hoch E; Cousijn J
    Addiction; 2020 Mar; 115(3):559-572. PubMed ID: 31408248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
    Bonnet U; Borda T; Scherbaum N; Specka M
    Drug Alcohol Depend; 2015 Oct; 155():302-6. PubMed ID: 26298553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder.
    Hooper SR; Woolley D; De Bellis MD
    Psychopharmacology (Berl); 2014 Apr; 231(8):1467-77. PubMed ID: 24619597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).
    Buckner JD; Heimberg RG; Schneier FR; Liu SM; Wang S; Blanco C
    Drug Alcohol Depend; 2012 Jul; 124(1-2):128-34. PubMed ID: 22266089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.
    Kuhns L; Kroon E; Colyer-Patel K; Cousijn J
    Psychopharmacology (Berl); 2022 May; 239(5):1231-1249. PubMed ID: 34741634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks associated with the non-medicinal use of cannabis.
    Hoch E; Bonnet U; Thomasius R; Ganzer F; Havemann-Reinecke U; Preuss UW
    Dtsch Arztebl Int; 2015 Apr; 112(16):271-8. PubMed ID: 25939318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
    Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
    Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis and development of dual diagnoses: A literature review.
    Hanna RC; Perez JM; Ghose S
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):442-455. PubMed ID: 27612527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness.
    Kozak K; H Smith P; Lowe DJE; Weinberger AH; Cooper ZD; Rabin RA; George TP
    Am J Drug Alcohol Abuse; 2021 Sep; 47(5):535-547. PubMed ID: 34280058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys.
    Onaemo VN; Fawehinmi TO; D'Arcy C
    J Affect Disord; 2021 Feb; 281():467-475. PubMed ID: 33360749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
    Butterworth P; Slade T; Degenhardt L
    Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and psychosis: an update on course and biological plausible mechanisms.
    Linszen D; van Amelsvoort T
    Curr Opin Psychiatry; 2007 Mar; 20(2):116-20. PubMed ID: 17278907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence.
    Agosti V; Nunes E; Levin F
    Am J Drug Alcohol Abuse; 2002 Nov; 28(4):643-52. PubMed ID: 12492261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.
    Wittchen HU; Fröhlich C; Behrendt S; Günther A; Rehm J; Zimmermann P; Lieb R; Perkonigg A
    Drug Alcohol Depend; 2007 Apr; 88 Suppl 1():S60-70. PubMed ID: 17257779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom.
    Arterberry BJ; Treloar Padovano H; Foster KT; Zucker RA; Hicks BM
    Drug Alcohol Depend; 2019 Feb; 195():186-192. PubMed ID: 30573162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a phone-based measure of impairment after acute oral ∆
    Pabon E; de Wit H
    J Psychopharmacol; 2019 Sep; 33(9):1160-1169. PubMed ID: 31407943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of comorbid psychopathology with the duration of cannabis use disorders.
    Farmer RF; Kosty DB; Seeley JR; Gau JM; Duncan SC; Walker DD; Lewinsohn PM
    Psychol Addict Behav; 2016 Feb; 30(1):82-92. PubMed ID: 26766543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.